MIRACLE2 Score Compared With Downtime and Current Selection Criterion for Invasive Cardiovascular Therapies After OHCA.
Aldous R, Roy R, Cannata A, Abdrazak M, Mohanan S, Beckley-Hoelscher N, Stahl D, Kanyal R, Kordis P, Sunderland N, Parczewska A, Kirresh A, Nevett J, Fothergill R, Webb I, Dworakowski R, Melikian N, Kalra S, Johnson TW, Sinagra G, Rakar S, Noc M, Patel S, Auzinger G, Gruchala M, Shah AM, Byrne J, MacCarthy P, Pareek N.
Aldous R, et al. Among authors: cannata a.
JACC Cardiovasc Interv. 2023 Oct 9;16(19):2439-2450. doi: 10.1016/j.jcin.2023.08.010. Epub 2023 Aug 21.
JACC Cardiovasc Interv. 2023.
PMID: 37609699
Free article.
Clinical Trial.